Richard Stryker

Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults

Schlomo Staszewski, Javier O Morales-Ramirez, Karen T. Tashima et al. · New England Journal of Medicine · 1999 · 1K citations · Full text

Sofosbuvir plus ribavirin for the treatment of chronic genotype 4 hepatitis C virus infection in patients of Egyptian ancestry

Peter Ruane, Dani Ain, Richard Stryker et al. · Journal of Hepatology · 2014 · 164 citations · Full text

Safety and Antiviral Activity at 48 Weeks of Lopinavir/Ritonavir plus Nevirapine and 2 Nucleoside Reverse‐Transcriptase Inhibitors in Human Immunodeficiency Virus Type 1–Infected Protease Inhibitor–Experienced Patients

Constance A. Benson, Steven G. Deeks, Scott C. Brun et al. · The Journal of Infectious Diseases · 2002 · 153 citations

A Phase I Study of HGP-30, a 30 Amino Acid Subunit of the Human Immunodeficiency Virus (HIV) p17 Synthetic Peptide Analogue Sub-unit Vaccine in Seronegative Subjects

JAMES O. KAHN, DANIEL P. STITES, J. J. Scillian et al. · AIDS Research and Human Retroviruses · 1992 · 27 citations

Laboratory Immunology, Immunology, Immunotherapeutics +20

Efficacy and tolerability of long-term efavirenz plus nucleoside reverse transcriptase inhibitors for HIV-1 infection

Karen T. Tashima, Schlomo Staszewski, Mark Nelson et al. · AIDS · 2008 · 19 citations